Clinical trial
A Study of Ataluren in Pediatric Participants With Cystic Fibrosis
NCT00458341 · PTC Therapeutics, Industry · Completed
Key facts
| NCT number | NCT00458341 |
|---|---|
| Title | A Study of Ataluren in Pediatric Participants With Cystic Fibrosis |
| Official title | A Phase 2 Study of PTC124 as an Oral Treatment for Nonsense-Mutation-Mediated Cystic Fibrosis |
| Lead sponsor | PTC Therapeutics, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cystic Fibrosis |
| Intervention type | Drug |
| Interventions | Ataluren |
| Enrollment | 30 |
| Start date | Mar 23, 2007 |
| Primary completion | Feb 29, 2008 |
| Completion | Feb 29, 2008 |
| First posted | Apr 10, 2007 |
| Last update posted | Mar 6, 2020 |
| Countries | Belgium, France |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: